Articles tagged with Personalized Medicine
A new book written by an international team from Carnegie Mellon University and the University of Oxford argues that data-driven decision-making can improve healthcare outcomes. The authors explain how analytics can be used to optimize hospital operations, manage bed allocation, and improve treatment efficiency.
A new approach enables hospital pharmacists to rapidly create bespoke medicine cartridges for rare disease patients, boosting access to personalized treatment. The NANOSPRESSO platform could open up treatments for underfunded and underserved rare conditions worldwide.
A new study found that over 1.74 million patients in Ontario are attached to family physicians aged 65 or older, with many having complex medical needs. The study highlights a decline in the number of early career physicians and an aging workforce nearing retirement.
Current risk-based regulatory approaches to AI in healthcare fall short, ignoring individual patient preferences and potential for bias. Authors call for introduction of patient rights relating to AI-generated diagnosis or treatment planning to protect patients' autonomy and trust.
The Association for Molecular Pathology publishes guidelines for detecting homologous recombination deficiency (HRD) in cancer. The report includes recommendations for clinical laboratories, addressing technical aspects of genomic instability and HRD analysis.
A dual-protective approach using Botox and an anti-nausea patch significantly reduces salivary gland toxicity in prostate cancer patients undergoing PSMA-targeted radiopharmaceutical therapy. This strategy led to a 30% decrease in PSMA uptake by the salivary glands without affecting the treatment's cancer-fighting efficacy.
Researchers have developed a test that can predict chemotherapy resistance in cancer patients, based on chromosomal instability signatures. This test has the potential to personalize treatment and reduce side effects for patients.
Researchers at University of Cologne have discovered a previously unknown mechanism that explains why many patients with aggressive B-cell lymphoma don't respond to CAR-T cell therapy. Combining this innovative treatment with CSF1R inhibitors improves its effectiveness, according to the study published in Cancer Cell.
The Association for Molecular Pathology (AMP) has announced the election results for 2026-2027 leadership positions, including President-Elect Yassmine M.N. Akkari and Secretary-Treasurer Jonathan A. Nowak. The newly elected leaders will drive AMP's mission to advance molecular diagnostics.
Researchers developed a dual-targeting radiopharmaceutical therapy that targets two key markers simultaneously, delivering radiation directly to tumors. The therapy showed strong and lasting uptake in tumors, allowing for high doses of targeted radiation to be delivered to cancer cells, resulting in 88.9% positive responses.
Researchers developed a new laboratory method that helps diagnose patients with suspected immune system disorders like activated-PI3Kδ syndrome (APDS). The method identified dozens of additional genetic variations associated with the condition, enabling rapid diagnosis and treatment. This breakthrough may also help identify more patien...
A new online toolkit developed by the University of Ottawa and Health Canada aims to educate healthcare providers on managing opioid-related issues. The toolkit's co-creation model involves patient input, leading to a deeper understanding of chronic pain and opioid use, and a more compassionate approach to care.
Researchers from Florida Atlantic University's Charles E. Schmidt College of Medicine aim to reduce falls and adverse drug events among older adults by using personalized approach tailored to individual genetic profiles.
Mount Sinai Health System will participate at the 2025 Aspen Ideas: Health festival, discussing emerging science of aging and inflammation, and harnessing AI for healthcare innovation. The system will also provide complimentary dermatologic screenings for attendees.
A recent survey by Ateneo de Manila University researchers highlights the challenges faced by young Filipino nursing and medicine graduates in finding stable employment and meaningful roles. Many new graduates feel lost and unsupported, with restricted hiring rules and budget ceilings forcing them to take on multiple roles without addi...
The Human Exposome Moonshot initiative aims to map the physical, chemical, biological and psychosocial exposures driving 80% of chronic diseases. The exposome project integrates advanced technologies to create a comprehensive understanding of environmental influences on health.
New radioimmunotherapy approaches show promise against advanced breast cancer and prostate cancer. Additionally, new imaging tools enhance cancer detection and diagnosis, while a proposed standard improves lesion interpretation. Cost-effectiveness studies also support novel therapies for rare digestive cancers.
Researchers developed an AI model that uses real-time data to diagnose nystagmus, a condition linked to vestibular or neurological disorders. The system allows patients to record their eye movements using a smartphone and receive remote diagnostic analysis.
A global study by UniSA researchers found that 94% of people who use wearable activity trackers are open to sharing their health information with healthcare providers. This could lead to more personalized and responsive care. The demand for personalized healthcare is on the rise, and wearable activity tracker market is increasing.
The Ochsner Health system implements pharmacogenomics to fine-tune treatments based on individual genetic profiles, transforming patient care through personalized medicine. Pharmacists play a pivotal role in spearheading these innovations, overcoming barriers and maximizing impact.
A University of the Basque Country study found that Bilbao's urban elements significantly impact physical activity levels. Citizens prioritized green areas, multi-purpose facilities, and accessibility, highlighting the importance of proper management and maintenance. The research also emphasized the need for pedestrian-friendly infrast...
Researchers discovered biomarkers in gut bacteria and metabolites that can help diagnose and treat gastrointestinal diseases. The study found that certain biomarkers could predict multiple diseases, including gastric cancer and inflammatory bowel disease.
The ISSCR has assembled an international consortium to support the adoption of human stem cell-derived disease models for drug discovery and development. This initiative aims to reduce R&D costs and accelerate therapy development, aligning with efforts by regulatory bodies such as the FDA, NIH, and European Commission.
Researchers have uncovered unique molecular fingerprints for insulin sensitivity, challenging traditional binary classification of people with type 2 diabetes. These signatures can help identify individuals at risk earlier than current methods, paving the way for personalized treatments and precision medicine.
New studies explore peptide receptor radionuclide therapy, targeted radiation for prostate cancer, and neuroendocrine tumor treatment. Targeted radiation boosts survival in colorectal liver cancer and bone metastases, while a new PET imaging tracer shows promise for detection.
A new combination therapy pairing radiopharmaceutical 177Lu-DOTATATE with DNA-repair blocker olaparib has been deemed feasible and tolerable for neuroendocrine cancer patients. Eighteen patients received the combined therapy, resulting in a 69% disease control rate at six months.
A new smartphone app, ECHAS, can help people determine if they are suffering from a heart attack or stroke and need medical attention. The app, developed by experts at UVA Health and other leading institutions, proved effective in identifying patients with cardiac and neurological emergencies.
A new study reveals that Aspergillus fumigatus infection can unbalance the lungs by creating a microaerophilic niche for bacteria like Ligilactobacillus murinus. This interaction may influence disease progression and enable new treatment approaches, highlighting the importance of understanding the gut-lung axis.
A new study by Queen Mary University of London found significant ethnic differences in breast cancer development and outcomes among women of African and South Asian genetic ancestry. Women from these backgrounds were diagnosed earlier and died younger than European-ancestry women, highlighting the need for tailored care approaches.
Researchers identified metabolite patterns in blood and urine related to ultra-processed food intake. A poly-metabolite score was developed, showing potential to objectively measure diet and reduce reliance on self-reported data.
A new technique using focused sound waves and microbubbles has shown great promise in treating debilitating brain lesions called cerebral cavernous malformations. The approach has halted the growth of lesions almost entirely, offering a potential paradigm shift in treatment.
The University of Texas at Arlington offers pre-health students valuable hands-on experience through an innovative collaboration. Students in SCIE 4304 participate in immersive clinical simulation lab at the UTA Smart Hospital, developing rudimentary clinical skills and overcoming imposter syndrome.
A new study found that a simple oral swab test can increase IVF success rates by identifying the best hormone treatment for each woman based on her genetic profile. The test, developed by researchers at Lund University, shows promise in reducing costs and increasing pregnancies.
The Human Exposome is a global scientific effort to understand the environmental factors that underpin disease and health. The Exposome Moonshot Forum aims to chart this exposome, providing usable metrics and data points for targeted public health interventions.
Serum Krebs von den Lungen-6 (KL-6) levels are significantly elevated in patients with interstitial lung disease (ILD), suggesting its potential as a diagnostic biomarker. The study also highlights the relationship between KL-6 levels and pulmonary function, specifically forced vital capacity.
A new study reveals a significant increase in ischemic heart disease prevalence across Southeast Asia, East Asia, and Oceania between 1990-2021. The regions experience distinct risk factors, including air pollution, dietary patterns, and high blood pressure.
A new survey by the Physicians Committee for Responsible Medicine reveals that half of U.S. adults believe a plant-based diet improves their health and prevents chronic diseases. Only 20% of primary care practitioners discuss this with patients, highlighting a missed opportunity to turn interest into action and reduce disease risk.
A groundbreaking study from the University of Virginia Health System reveals distinct immune patterns in patients with persistent breathing issues after COVID-19. The research identifies specific T cell changes linked to lung damage and fibrosis, paving the way for personalized treatments.
Scientists at Henry Ford Health + Michigan State University Health Sciences have identified a circulating microRNA called miR-126-3p as a mechanistic biomarker of knee osteoarthritis. This discovery may lead to the development of blood tests for early detection and therapeutics for slowing or stopping disease progression.
The journal is seeking submissions to a new theme issue exploring the importance of telerehabilitation and future directions for the field. Researchers will focus on implementation challenges, health equity concerns, and emerging innovations like AI-driven personalized rehabilitation.
Researchers at TUM developed an AI-powered algorithm to predict kidney damage in prostate cancer patients undergoing lutetium-177 PSMA therapy. Early detection could enable personalized treatment adjustments to prevent organ damage.
A UT Health San Antonio-led discovery could redefine drug discovery by turning IV medications into orally administered treatments for brain cancer, Alzheimer’s disease, and other complex conditions. The new strategy uses a protein receptor called CD36 to efficiently deliver large molecules into cells.
The University of Missouri is partnering with a consortium to design and license a new research reactor, NextGen MURR, which will produce critical medical isotopes for cancer treatment. The project aims to enhance Missouri's role as a leader in nuclear science and medical research.
Researchers developed fluorescent polyionic nanoclays that can be customized for medical imaging, sensor technology, and environmental protection. These tiny clay-based materials exhibit high brightness and versatility, enabling precise tuning of optical properties.
Researchers used data from 9,000 pregnancies to discover and validate RNA signatures that distinguish between severe and mild hypertensive disorders of pregnancy. The study validates Mirvie's simple blood test to predict preeclampsia early, at 17.5-22 weeks gestational age.
Aging (Aging-US) journal announces a commemorative collection honoring Dr. Mikhail Blagosklonny, a pioneer in aging biology. The special issue will explore key themes central to his scientific contributions, including mechanistic insights and translational approaches.
A new Electronic Frailty Index 2 (eFI2) system will improve the accuracy of identifying older people's frailty by integrating data on 36 health problems. This will enable GPs to provide personalized treatments to prevent costly loss of independence and falls in older age.
Researchers at Lancaster University discovered a new type of vaccine-specific scepticism, where some people perceive COVID-19 vaccines as 'not a vaccine' compared to MMR. This phenomenon may also apply to the flu vaccine, highlighting the need for clear public health messaging.
Researchers developed a new diagnostic platform that classifies brain tumors based on the body's cancer-fighting immune response. The approach tailors treatment options to each patient's unique immune profile, offering improved diagnostics and potential for immunotherapies to revolutionize childhood leukemia treatments.
A new theme issue in the Canadian Journal of Cardiology emphasizes the importance of personalized heart health advice considering individual differences. The issue highlights disparities in sports participation and related health outcomes between males and females as well as socioeconomic disparities, with women showing a lower risk of...
Fentanyl poisoning among US children has surged by 924% and 1,506% for teens aged 13-19 over the past eight years. Parents are advised to be vigilant about hidden fentanyl risks and know the signs of overdose symptoms to save their children.
A new study found that the proportion of visceral fat, rather than the absolute amount, is a stronger predictor of high triglyceride levels and inflammation. Lowering visceral fat proportion during weight loss can lead to better metabolic health outcomes.
The new AI model leverages hypergraphs to quickly and accurately identify therapeutic gene targets for diseases. HIT outperformed existing models in all tested metrics, demonstrating its accuracy in classifying therapeutic gene targets with great precision.
La Jolla Institute scientists found that a protein in brain cells drives Parkinson's onset and may explain why the disease is more common in men. PINK1 appears to mark brain cells for immune cell attack, leading to inflammation and death.
Researchers introduce a dual threshold classifier to interpret circulating tumor DNA levels, enabling earlier detection of disease progression and personalized treatment. The study confirms that ctDNA levels are superior to traditional biomarkers like CA15-3.
A recent MSU study highlights the challenges of diagnosing episodic disabilities like epilepsy, where symptoms fluctuate and can be unpredictable. The research found that 52% of participants experienced delayed diagnoses, while others faced quick confirmations within days of their first seizure.
A new study from the University of Texas at Arlington found that Americans aged 65 and older who experienced parental divorce as children were more likely to suffer a stroke compared to their peers. The study analyzed data from over 13,000 older Americans and found that about 14% had experienced parental divorce during childhood.
Researchers at the Institute for Systems Biology (ISB) have developed a breakthrough method to track diet using stool metagenomic data. The MEDI approach detects food-derived DNA in stool samples to estimate dietary intake, offering a convenient alternative to traditional methods that suffer from misreporting and compliance issues.
A large study found that telemedicine and training apps had minimal positive effects on patients with type 2 diabetes and coronary heart disease. The study suggests that direct care from medical professionals remains crucial for improving health outcomes in this population.
A groundbreaking study analyzed data from over 78,000 cancer patients to identify nearly 800 genetic changes impacting survival outcomes. The research also discovered genes significantly associated with survival in various cancers, such as breast, ovarian, skin, and gastrointestinal cancers.